121 related articles for article (PubMed ID: 25753185)
1. Activation of G-protein coupled estrogen receptor inhibits the proliferation of cervical cancer cells via sustained activation of ERK1/2.
Zhang Q; Wu YZ; Zhang YM; Ji XH; Hao Q
Cell Biochem Funct; 2015 Apr; 33(3):134-42. PubMed ID: 25753185
[TBL] [Abstract][Full Text] [Related]
2. Expression and signaling of G protein-coupled estrogen receptor 1 (GPER) in rat sertoli cells.
Lucas TF; Royer C; Siu ER; Lazari MF; Porto CS
Biol Reprod; 2010 Aug; 83(2):307-17. PubMed ID: 20445128
[TBL] [Abstract][Full Text] [Related]
3. Activation of GPR30 inhibits the growth of prostate cancer cells through sustained activation of Erk1/2, c-jun/c-fos-dependent upregulation of p21, and induction of G(2) cell-cycle arrest.
Chan QK; Lam HM; Ng CF; Lee AY; Chan ES; Ng HK; Ho SM; Lau KM
Cell Death Differ; 2010 Sep; 17(9):1511-23. PubMed ID: 20203690
[TBL] [Abstract][Full Text] [Related]
4. GPER agonist G-1 decreases adrenocortical carcinoma (ACC) cell growth in vitro and in vivo.
Chimento A; Sirianni R; Casaburi I; Zolea F; Rizza P; Avena P; Malivindi R; De Luca A; Campana C; Martire E; Domanico F; Fallo F; Carpinelli G; Cerquetti L; Amendola D; Stigliano A; Pezzi V
Oncotarget; 2015 Aug; 6(22):19190-203. PubMed ID: 26131713
[TBL] [Abstract][Full Text] [Related]
5. Benzopyran derivative CDRI-85/287 induces G2-M arrest in estrogen receptor-positive breast cancer cells via modulation of estrogen receptors α- and β-mediated signaling, in parallel to EGFR signaling and suppresses the growth of tumor xenograft.
Saxena R; Fatima I; Chandra V; Blesson CS; Kharkwal G; Hussain MK; Hajela K; Roy BG; Dwivedi A
Steroids; 2013 Nov; 78(11):1071-86. PubMed ID: 23891847
[TBL] [Abstract][Full Text] [Related]
6. SIRT1 is involved in oncogenic signaling mediated by GPER in breast cancer.
Santolla MF; Avino S; Pellegrino M; De Francesco EM; De Marco P; Lappano R; Vivacqua A; Cirillo F; Rigiracciolo DC; Scarpelli A; Abonante S; Maggiolini M
Cell Death Dis; 2015 Jul; 6(7):e1834. PubMed ID: 26225773
[TBL] [Abstract][Full Text] [Related]
7. G protein-coupled estrogen receptor 1 agonist G-1 induces cell cycle arrest in the mitotic phase, leading to apoptosis in endometriosis.
Mori T; Ito F; Matsushima H; Takaoka O; Tanaka Y; Koshiba A; Kusuki I; Kitawaki J
Fertil Steril; 2015 May; 103(5):1228-35.e1. PubMed ID: 25724739
[TBL] [Abstract][Full Text] [Related]
8. The activation of G protein-coupled estrogen receptor induces relaxation via cAMP as well as potentiates contraction via EGFR transactivation in porcine coronary arteries.
Yu X; Stallone JN; Heaps CL; Han G
PLoS One; 2018; 13(1):e0191418. PubMed ID: 29360846
[TBL] [Abstract][Full Text] [Related]
9. Epigenetic down regulation of G protein-coupled estrogen receptor (GPER) functions as a tumor suppressor in colorectal cancer.
Liu Q; Chen Z; Jiang G; Zhou Y; Yang X; Huang H; Liu H; Du J; Wang H
Mol Cancer; 2017 May; 16(1):87. PubMed ID: 28476123
[TBL] [Abstract][Full Text] [Related]
10. Co-stimulation with stem cell factor and erythropoietin enhances migration of c-Kit expressing cervical cancer cells through the sustained activation of ERK1/2.
Aguilar C; Aguilar C; Lopez-Marure R; Jiménez-Sánchez A; Rocha-Zavaleta L
Mol Med Rep; 2014 May; 9(5):1895-902. PubMed ID: 24626629
[TBL] [Abstract][Full Text] [Related]
11. The activation of the G protein-coupled estrogen receptor (GPER) inhibits the proliferation of mouse melanoma K1735-M2 cells.
Ribeiro MPC; Santos AE; Custódio JBA
Chem Biol Interact; 2017 Nov; 277():176-184. PubMed ID: 28947257
[TBL] [Abstract][Full Text] [Related]
12. Activation of the calcium-sensing receptor by high calcium induced breast cancer cell proliferation and TRPC1 cation channel over-expression potentially through EGFR pathways.
El Hiani Y; Lehen'kyi V; Ouadid-Ahidouch H; Ahidouch A
Arch Biochem Biophys; 2009 Jun; 486(1):58-63. PubMed ID: 19332022
[TBL] [Abstract][Full Text] [Related]
13. G protein-coupled estrogen receptor-1 agonist induces chemotherapeutic effect via ER stress signaling in gastric cancer.
Lee SJ; Kim TW; Park GL; Hwang YS; Cho HJ; Kim JT; Lee HG
BMB Rep; 2019 Nov; 52(11):647-652. PubMed ID: 31234952
[TBL] [Abstract][Full Text] [Related]
14. GPER mediates enhanced cell viability and motility via non-genomic signaling induced by 17β-estradiol in triple-negative breast cancer cells.
Yu T; Liu M; Luo H; Wu C; Tang X; Tang S; Hu P; Yan Y; Wang Z; Tu G
J Steroid Biochem Mol Biol; 2014 Sep; 143():392-403. PubMed ID: 24874276
[TBL] [Abstract][Full Text] [Related]
15. Activation of GPER Induces Differentiation and Inhibition of Coronary Artery Smooth Muscle Cell Proliferation.
Li F; Yu X; Szynkarski CK; Meng C; Zhou B; Barhoumi R; White RE; Heaps CL; Stallone JN; Han G
PLoS One; 2013; 8(6):e64771. PubMed ID: 23840305
[TBL] [Abstract][Full Text] [Related]
16. Activation of G-Protein-Coupled Estrogen Receptor Inhibits the Migration of Human Nonsmall Cell Lung Cancer Cells via IKK-β/NF-κB Signals.
Zhu G; Huang Y; Wu C; Wei D; Shi Y
DNA Cell Biol; 2016 Aug; 35(8):434-42. PubMed ID: 27082459
[TBL] [Abstract][Full Text] [Related]
17. G protein-coupled estrogen receptor 1 (GPER1)/GPR30 increases ERK1/2 activity through PDZ motif-dependent and -independent mechanisms.
Gonzalez de Valdivia E; Broselid S; Kahn R; Olde B; Leeb-Lundberg LMF
J Biol Chem; 2017 Jun; 292(24):9932-9943. PubMed ID: 28450397
[TBL] [Abstract][Full Text] [Related]
18. Synthesis and study of benzothiazole conjugates in the control of cell proliferation by modulating Ras/MEK/ERK-dependent pathway in MCF-7 cells.
Kamal A; Faazil S; Ramaiah MJ; Ashraf M; Balakrishna M; Pushpavalli SN; Patel N; Pal-Bhadra M
Bioorg Med Chem Lett; 2013 Oct; 23(20):5733-9. PubMed ID: 23999041
[TBL] [Abstract][Full Text] [Related]
19. MEHP promotes the proliferation of cervical cancer via GPER mediated activation of Akt.
Yang W; Tan W; Zheng J; Zhang B; Li H; Li X
Eur J Pharmacol; 2018 Apr; 824():11-16. PubMed ID: 29382535
[TBL] [Abstract][Full Text] [Related]
20. GPER-mediated proliferation and estradiol production in breast cancer-associated fibroblasts.
Luo H; Yang G; Yu T; Luo S; Wu C; Sun Y; Liu M; Tu G
Endocr Relat Cancer; 2014 Apr; 21(2):355-69. PubMed ID: 24481325
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
